A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Dry Eye Syndromes

In brief

A prospective, randomized, placebo and active comparator controlled study of CP-690,550 in subjects with dry eye.

Key facts

Study ID

NCT00784719

Run by

Pfizer

People needed

327

Starts

2008-11-01

Expected to finish

2009-10-01

Last updated by the study team

2013-04-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Symptoms of dry eye for at least 6 months.
• Signs of moderate to severe dry eye

You may not qualify if…

• Women who are nursing or pregnant
• Participation in other studies within 30 days of screening visit
• Ocular disorders that may confound interpretation of study results

Where it is running

• Pfizer Investigational Site — Chandler, Arizona, United States
• Pfizer Investigational Site — Peoria, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Artesia, California, United States
• Pfizer Investigational Site — Centennial, Colorado, United States
• Pfizer Investigational Site — Ormond Beach, Florida, United States
• Pfizer Investigational Site — Stuart, Florida, United States
• Pfizer Investigational Site — Tamarac, Florida, United States
• Pfizer Investigational Site — Tampa, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Morrow, Georgia, United States
• Pfizer Investigational Site — Roswell, Georgia, United States
• Pfizer Investigational Site — Louisville, Kentucky, United States
• Pfizer Investigational Site — Baltimore, Maryland, United States
• Pfizer Investigational Site — Boston, Massachusetts, United States
• Pfizer Investigational Site — Kansas City, Missouri, United States
• Pfizer Investigational Site — Lynbrook, New York, United States
• Pfizer Investigational Site — Rochester, New York, United States
• Pfizer Investigational Site — Charlotte, North Carolina, United States
• Pfizer Investigational Site — High Point, North Carolina, United States
• Pfizer Investigational Site — Cleveland, Ohio, United States
• Pfizer Investigational Site — Columbus, Ohio, United States
• Pfizer Investigational Site — Memphis, Tennessee, United States
• Pfizer Investigational Site — Austin, Texas, United States
• Pfizer Investigational Site — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.